Glaxo slide holds Footsie back
A sharp fall in the shares of drugs giant GlaxoSmithKline today prevented the FTSE 100 Index from closing at a four-year high.
Investors took fright at the proposals from regulators in the United States that tougher restrictions be placed on the Advair asthma treatment of Glaxo.